InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
1.190
-0.040 (-3.25%)
Dec 23, 2025, 3:03 PM EST - Market open
InterCure Market Cap
InterCure has a market cap or net worth of $67.29 million as of December 23, 2025. Its market cap has increased by 12.67% in one year.
Market Cap
67.29M
Enterprise Value
107.55M
1-Year Change
12.67%
Ranking
Category
Stock Price
$1.19
Market Cap Chart
Since December 16, 2010, InterCure's market cap has increased from $1.78M to $67.29M, an increase of 3,677.83%. That is a compound annual growth rate of 27.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 65.60M | -12.08% |
| Dec 31, 2024 | 74.61M | 27.32% |
| Dec 31, 2023 | 58.60M | -62.52% |
| Dec 29, 2022 | 156.35M | -47.90% |
| Dec 30, 2021 | 300.11M | 119.01% |
| Dec 31, 2020 | 137.03M | 17.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.35B |
| Johnson & Johnson | 497.21B |
| AbbVie | 400.88B |
| UnitedHealth Group | 296.59B |
| AstraZeneca | 283.55B |
| Novartis AG | 261.76B |
| Merck & Co. | 250.91B |
| Abbott Laboratories | 218.14B |